PMID: 4103945Jul 1, 1971

Myocardial infarction and oral contraceptive agents

The American Journal of Cardiology
E B WaxlerW Likoff


No abstract listed.


Oct 1, 1979·American Heart Journal·J A Erlebacher
Jun 1, 1975·Journal of Steroid Biochemistry·P Beck
Aug 29, 1974·The New England Journal of Medicine·A H Khan, L J Haywood
Sep 1, 1976·The American Journal of Cardiology·D C MorrisR B Logue
May 1, 1976·Postgraduate Medicine·R ZelisB H Roberts


Mar 1, 1967·The American Journal of Cardiology·O RothG D Wolff
Oct 1, 1969·The American Journal of Cardiology·C Stout
Nov 1, 1966·Journal of Chronic Diseases·R E Tracy
Mar 1, 1967·The American Journal of Cardiology·W J Walker, G Gregoratos
Feb 1, 1957·Annals of Internal Medicine·H L WEINREDB ROSENBERG
Feb 1, 1963·Journal of Chronic Diseases·R W ROBINSONW D COHEN
Jan 2, 1965·British Medical Journal·F HARTVEIT
Jul 2, 1966·British Medical Journal·L Poller, J M Thomson

Related Concepts

Myocardial Infarction
Dimethisterone Monohydrate
Blood Coagulation
Chlormadinone Acetate, (9 beta,10 alpha)-Isomer
Oral Contraceptives, Phasic
Progynon C
Coronary Angiography
Norethindrone, (1 beta)-Isomer

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.